ImmuCell
ICCC
ICCC
26 hedge funds and large institutions have $5.03M invested in ImmuCell in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $7.26M → $5.03M (-$2.24M)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$286K | |
| 2 | +$26K | |
| 3 | +$20.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.21K |
| 5 |
BlackRock
New York
|
+$2.34K |
Top Sellers
| 1 | -$120K | |
| 2 | -$87.3K | |
| 3 | -$46.9K | |
| 4 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$14.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.6K |